The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
124289912 12428991 2 F 20151112 20160718 20160602 20160729 EXP BE-CELGENEUS-BEL-2015115010 CELGENE 72.00 YR M Y 70.00000 KG 20160729 OT BE BE

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
124289912 12428991 1 PS ABRAXANE PACLITAXEL 1 Intravenous drip Y U 21660 170.38 MG INJECTION FOR INFUSION
124289912 12428991 2 SS ABRAXANE PACLITAXEL 1 Intravenous drip Y U 21660 170.38 MG INJECTION FOR INFUSION
124289912 12428991 3 SS GEMCITABINE GEMCITABINEGEMCITABINE HYDROCHLORIDE 1 Intravenous drip Y Y 0 1363.06 MG INJECTION FOR INFUSION
124289912 12428991 4 SS GEMCITABINE GEMCITABINEGEMCITABINE HYDROCHLORIDE 1 Intravenous drip Y Y 0 1363.06 MG INJECTION FOR INFUSION
124289912 12428991 5 C CRESTOR ROSUVASTATIN CALCIUM 1 Oral 0 10 MG UNKNOWN QD
124289912 12428991 6 C ZOLPIDEM ZOLPIDEMOLPIDEM TARTRATE 1 Oral 0 10 MG UNKNOWN QD
124289912 12428991 7 C XANAX ALPRAZOLAM 1 Oral 0 .5 MG UNKNOWN QD
124289912 12428991 8 C clexane ENOXAPARIN SODIUM 1 Subcutaneous 0 100 MG UNKNOWN QD
124289912 12428991 9 C litican ALIZAPRIDE HYDROCHLORIDE 1 Oral 0 50 MG UNKNOWN
124289912 12428991 10 C litican ALIZAPRIDE HYDROCHLORIDE 1 Oral 0 50 MG UNKNOWN
124289912 12428991 11 C perio-aid 2 Oral 1 UNIT 0 UNKNOWN

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
124289912 12428991 1 Pancreatic carcinoma
124289912 12428991 3 Pancreatic carcinoma
124289912 12428991 5 Hypercholesterolaemia
124289912 12428991 6 Insomnia
124289912 12428991 7 Insomnia
124289912 12428991 8 Thrombosis
124289912 12428991 9 Nausea
124289912 12428991 11 Prophylaxis

Outcome of event

Event ID CASEID OUTC COD
124289912 12428991 HO

Reactions reported

Event ID CASEID DRUG REC ACT PT
124289912 12428991 Anaemia
124289912 12428991 Decreased appetite
124289912 12428991 Diarrhoea
124289912 12428991 Fatigue
124289912 12428991 Hypokalaemia
124289912 12428991 Hypomagnesaemia
124289912 12428991 Nausea
124289912 12428991 Pyrexia
124289912 12428991 Vomiting
124289912 12428991 Weight decreased Weight decreased

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
124289912 12428991 1 20150922 20151201 0
124289912 12428991 2 20151222 0
124289912 12428991 3 20150922 20151201 0
124289912 12428991 4 20150922 0
124289912 12428991 5 2010 0
124289912 12428991 6 201509 0
124289912 12428991 7 201509 0
124289912 12428991 8 20150921 0
124289912 12428991 9 20151006 0
124289912 12428991 10 20151201 0
124289912 12428991 11 20151020 0